Walleye Capital’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$73.5M Buy
206,400
+191,700
+1,304% +$61.7M 0.07% 257
2026
Q2
$7.1M Sell
14,700
-14,600
-50% -$3.87M 0.03% 632
2026
Q1
$3.21M Sell
29,300
-38,500
-57% -$5.48M 0.01% 1095
2025
Q4
$11.3M Sell
67,800
-3,600
-5% -$602K 0.03% 578
2025
Q3
$14M Buy
71,400
+10,500
+17% +$1.73M 0.05% 396
2025
Q2
$5.51M Buy
60,900
+60,700
+30,350% +$4.8M 0.02% 821
2025
Q1
$11.9K Sell
200
-2,800
-93% -$259K ﹤0.01% 4055
2024
Q4
$397K Buy
3,000
+2,200
+275% +$206K ﹤0.01% 3179
2024
Q3
$41.9K Buy
+800
New +$37.5K ﹤0.01% 4681

Other funds holding ALAB

Walleye Capital's ALAB Position: Q3 2026 in Review

Walleye Capital increased its Astera Labs (ALAB) stake by 1,054% in Q3 2026, buying an estimated $29.9M and bringing the position to 101,614 shares worth $36.2M. The position accounts for 0.03% of the portfolio, ranked #506.

Walleye Capital first reported a position in ALAB in Q1 2024 and has held it in 11 quarters since. 989 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • Walleye Capital held 101,614 shares of Astera Labs worth $36.2M as of Q3 2026.
  • Walleye Capital bought 92,808 Astera Labs shares in Q3 2026, an estimated $29.9M.
  • Astera Labs made up 0.03% of Walleye Capital's portfolio in Q3 2026, its #506 holding.
  • Walleye Capital first reported a position in Astera Labs in Q1 2024 and has held it in 11 quarters since.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.